Filed: 1/5/2024ACC: 0000950123-24-000049
📋 What this filing means
VIDA VENTURES ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $84.00M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$84.00M
Total AUM (reported)
15.29M
Total Shares
Allocation by class
COMMON STOCK$42.50M50.6%
ORDINARY SHARES$41.50M49.4%
Portfolio Concentration
Top 3$69.09M82.3%
4–10$14.90M17.7%
Top 3 weight
82.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 15.29M
Sole
Full voting authority
15.29M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:
Centessa Pharmaceuticals plc
SOLEShares3.93M
TypeSH
Market value$31.30M
37.26%
Sole
3.93M
Shared
0.00
None
0.00
Dyne Therapeutics, Inc.
SOLEShares2.07M
TypeSH
Market value$27.59M
32.85%
Sole
2.07M
Shared
0.00
None
0.00
LianBio
SOLEShares2.28M
TypeSH
Market value$10.20M
12.14%
Sole
2.28M
Shared
0.00
None
0.00
Allogene Therapeutics, Inc.
SOLEShares1.80M
TypeSH
Market value$5.77M
6.87%
Sole
1.80M
Shared
0.00
None
0.00
Kinnate Biopharma, Inc.
SOLEShares2.21M
TypeSH
Market value$5.23M
6.23%
Sole
2.21M
Shared
0.00
None
0.00
Kronos Bio, Inc.
SOLEShares2.77M
TypeSH
Market value$3.46M
4.12%
Sole
2.77M
Shared
0.00
None
0.00
Ikena Oncology, Inc.
SOLEShares225.19K
TypeSH
Market value$443.6K
0.53%
Sole
225.19K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Centessa Pharmaceuticals plcSOLE | Ordinary Shares | 3.93M | SH | $31.30M 37.26% | 3.93M | 0.00 | 0.00 |
Dyne Therapeutics, Inc.SOLE | Common Stock | 2.07M | SH | $27.59M 32.85% | 2.07M | 0.00 | 0.00 |
LianBioSOLE | Ordinary Shares | 2.28M | SH | $10.20M 12.14% | 2.28M | 0.00 | 0.00 |
Allogene Therapeutics, Inc.SOLE | Common Stock | 1.80M | SH | $5.77M 6.87% | 1.80M | 0.00 | 0.00 |
Kinnate Biopharma, Inc.SOLE | Common Stock | 2.21M | SH | $5.23M 6.23% | 2.21M | 0.00 | 0.00 |
Kronos Bio, Inc.SOLE | Common Stock | 2.77M | SH | $3.46M 4.12% | 2.77M | 0.00 | 0.00 |
Ikena Oncology, Inc.SOLE | Common Stock | 225.19K | SH | $443.6K 0.53% | 225.19K | 0.00 | 0.00 |